An Open-label, Single Dose, Parallel Design, Phase I Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Oral Dosage Form of LCB01-0371 in Healthy Volunteers

Trial Profile

An Open-label, Single Dose, Parallel Design, Phase I Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Oral Dosage Form of LCB01-0371 in Healthy Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 11 Apr 2016

At a glance

  • Drugs LCB01-0371 (Primary)
  • Indications Bacterial infections; Gram-positive infections
  • Focus Pharmacokinetics
  • Sponsors LegoChem Biosciences
  • Most Recent Events

    • 07 Apr 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 25 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top